| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 3.792 | 10.525 | 10.458 | 8.510 | 6.848 |
| Total Income - EUR | - | - | - | - | 0 | 15.675 | 34.675 | 17.345 | 18.138 | 13.736 |
| Total Expenses - EUR | - | - | - | - | 634 | 35.754 | 40.469 | 28.504 | 17.741 | 13.386 |
| Gross Profit/Loss - EUR | - | - | - | - | -634 | -20.079 | -5.794 | -11.159 | 397 | 349 |
| Net Profit/Loss - EUR | - | - | - | - | -634 | -20.149 | -5.985 | -11.346 | 236 | 267 |
| Employees | - | - | - | - | 0 | 5 | 5 | 4 | 4 | 0 |
Check the financial reports for the company - Biofruct Ancora S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 1.816 | 34.644 | 27.604 | 21.399 | 17.198 | 13.149 |
| Current Assets | - | - | - | - | 26.421 | 4.561 | 8.085 | 9.739 | 11.482 | 11.530 |
| Inventories | - | - | - | - | 461 | 2.776 | 5.369 | 6.765 | 7.246 | 6.531 |
| Receivables | - | - | - | - | 25.843 | 0 | 177 | 932 | 2.395 | 1.111 |
| Cash | - | - | - | - | 117 | 1.785 | 2.539 | 2.042 | 1.841 | 3.889 |
| Shareholders Funds | - | - | - | - | -592 | -20.730 | -26.255 | -37.683 | -37.333 | -36.857 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 28.829 | 21.906 | 34.375 | 47.456 | 48.850 | 48.388 |
| Income in Advance | - | - | - | - | 0 | 38.028 | 27.570 | 21.364 | 17.164 | 13.149 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1032 - 1032" | |||||||||
| CAEN Financial Year |
1032
|
|||||||||
Comments - Biofruct Ancora S.r.l.